Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$40.97 - $43.33 $157,734 - $166,820
3,850 Added 31.0%
16,268 $688,000
Q4 2023

Feb 12, 2024

BUY
$32.77 - $42.31 $46,861 - $60,503
1,430 Added 13.01%
12,418 $518,000
Q3 2023

Nov 14, 2023

BUY
$35.46 - $40.13 $389,634 - $440,948
10,988 New
10,988 $414,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.